- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding restated | Q1 2026 · May 4, 2026 | 10.72M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2026 | 10.68M sh |
| Shares Diluted | Q1 2026 · Mar 30, 2025 | 10.95M sh |
| Operating Cash Flow | Q1 2026 · Mar 29, 2026 | $4K |
| Operating Cash Flow | Q1 2026 · Mar 30, 2025 | $1.06M |
| Short Term Investments | Q1 2026 · Mar 29, 2026 | $5M |
| Short Term Investments | Q1 2026 · Dec 28, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 29, 2026 | $13.9M |
| Cash And Equivalents | Q1 2026 · Dec 28, 2025 | $19.02M |
| Stockholders Equity | Q1 2026 · Mar 29, 2026 | $46.99M |
| Stockholders Equity | Q1 2026 · Dec 28, 2025 | $48.11M |
| Stockholders Equity | Q1 2026 · Mar 30, 2025 | $81.82M |
| Stockholders Equity | Q1 2026 · Dec 29, 2024 | $82.27M |
| Current Liabilities | Q1 2026 · Mar 29, 2026 | $6.14M |
| Current Liabilities | Q1 2026 · Dec 28, 2025 | $9.33M |
| Total Liabilities | Q1 2026 · Mar 29, 2026 | $6.39M |
| Total Liabilities | Q1 2026 · Dec 28, 2025 | $9.73M |
| Current Assets | Q1 2026 · Mar 29, 2026 | $34.3M |
| Current Assets | Q1 2026 · Dec 28, 2025 | $38.45M |
| Total Assets | Q1 2026 · Mar 29, 2026 | $53.38M |
| Total Assets | Q1 2026 · Dec 28, 2025 | $57.84M |
| Eps Basic | Q1 2026 · Mar 29, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 30, 2025 | −$0.07 |
| Sga Expense | Q1 2026 · Mar 29, 2026 | $8.81M |
| Sga Expense restated | Q1 2026 · Mar 30, 2025 | $9M |
| Net Income | Q1 2026 · Mar 29, 2026 | −$471K |
| Net Income | Q1 2026 · Mar 30, 2025 | −$722K |
| Operating Income | Q1 2026 · Mar 29, 2026 | −$1.55M |
| Operating Income restated | Q1 2026 · Mar 30, 2025 | −$1.77M |
| Gross Profit | Q1 2026 · Mar 29, 2026 | $7.41M |
| Gross Profit restated | Q1 2026 · Mar 30, 2025 | $7.56M |
| Cost Of Revenue | Q1 2026 · Mar 29, 2026 | $13.47M |
| Cost Of Revenue restated | Q1 2026 · Mar 30, 2025 | $13.32M |
| Revenue | Q1 2026 · Mar 29, 2026 | $20.88M |
| Revenue restated | Q1 2026 · Mar 30, 2025 | $20.88M |